Cathy Klema, Director at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 8,000 shares at $43.79 ($349K) on 2008-05-28, disclosed to the SEC on 2008-05-29.
Open-market sale of $349k PPDI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.42 | 100 | $4K | 1.2% |
| 2 | $43.44 | 200 | $9K | 2.5% |
| 3 | $43.45 | 300 | $13K | 3.7% |
| 4 | $43.48 | 500 | $22K | 6.2% |
| 5 | $43.49 | 100 | $4K | 1.2% |
| 6 | $43.50 | 600 |
| $26K |
| 7.5% |
| 7 | $43.53 | 200 | $9K | 2.5% |
| 8 | $43.54 | 200 | $9K | 2.5% |
| 9 | $43.55 | 100 | $4K | 1.2% |
| 10 | $43.56 | 700 | $30K | 8.7% |
| 11 | $43.57 | 700 | $30K | 8.7% |
| 12 | $43.58 | 900 | $39K | 11.2% |
| 13 | $43.59 | 200 | $9K | 2.5% |
| 14 | $43.60 | 300 | $13K | 3.8% |
| 15 | $43.61 | 833 | $36K | 10.4% |
| 16 | $43.63 | 367 | $16K | 4.6% |
| 17 | $43.64 | 100 | $4K | 1.3% |
| 18 | $43.66 | 100 | $4K | 1.3% |
| 19 | $43.67 | 200 | $9K | 2.5% |
| 20 | $43.68 | 200 | $9K | 2.5% |
| 21 | $43.69 | 300 | $13K | 3.8% |
| 22 | $43.73 | 300 | $13K | 3.8% |
| 23 | $43.74 | 100 | $4K | 1.3% |
| 24 | $43.75 | 174 | $8K | 2.2% |
| 25 | $43.79 | 226 | $10K | 2.8% |
| Total | $43.59 avg | 8,000 | $349K | 100% |
| Filing → |
| PPDI | SELL | 2007-05-23 | $426K | — | Filing → |
| PPDI | SELL | 2006-02-28 | $280K | — | Filing → |